LAB vs PODD · rev $174.4M vs P/E 34, rev $2.07B
Standard Biotools Inc (LAB) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
LAB currently screens at market cap $317.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the LAB and PODD stock pages for the full models.
Not investment advice.